Science ❯ Medical Science ❯ Vaccine Development ❯ mRNA Technology

Clinical Trials

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

Scientists and former health leaders say the reversal undermines rapid vaccine readiness and risks ceding biotech leadership abroad.

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms